Courtney Schadt is a Dermatology physician. OpenAlex indexes 61 publications with 887 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1301 Medical Center Dr
Nashville, TN 372320028
Telephone
615-322-5000Provider last certified this registry record 5 May 2026.
Clinical trials
- Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients
Sponsor: Vanderbilt University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year20251 payment
- UCB, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
34.6%Azole Antifungal20.2%Ketoconazole100%Part D≥113 patientsTetracycline-class Drug7%Doxycycline Hyclate78%Doxycycline Monohydrate22%Part D<11 patients+ 4 more classes in this area
Dermatology
17.4%Corticosteroid12%Triamcinolone Acetonide100%Part D≥89 patientsInterleukin-4 Receptor alpha Antagonist4.3%Dupixent Pen100%Part D<11 patients+ 1 more class in this area
Sensory organs
14.5%Corticosteroid14.5%Hydrocortisone50%Clobetasol Propionate38%Betamethasone Dipropionate11%Part D≥59 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dermatitis Herpetiformis Associated with Celiac Disease Exacerbated by Enfortumab Vedotin-ejfv and Pembrolizumab
Journal of Dermatology & Dermatologic Surgery
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”